Stephen Kates, certified financial planner and principal at Clocktower Financial Consulting, on the Fed's rate decision, GDP and what to watch in the job market

Stephen Kates, certified financial planner and principal at Clocktower Financial Consulting, on the Fed's rate decision, GDP and what to watch in the job market

Stephen Kates, certified financial planner and principal at Clocktower Financial Consulting, joins Lisa Price to break down a busy stretch of economic data, including the Federal Reserve's July decision to hold rates steady despite three dissenting votes in favor of a hike and rising expectations of a September increase. Kates also discusses a disappointing first estimate of second quarter GDP coming in at 1.5%, a slight cooling in core PCE inflation from 3.4% to 3.3%, and what today's JOLTS report on job openings, hiring and layoffs will reveal about the health of the labor market.

Charlotte West, vice president at Surest, on understanding your health coverage options before enrollment season

Charlotte West, vice president at Surest, joins Lisa Price to discuss the growing financial burden of healthcare costs, with nearly 12% of adults skipping care due to cost and half unable to cover a surprise $500 medical bill. West breaks down the alternatives to standard health plans, including upfront-pricing plans, HSAs, FSAs and value-based care options, and what consumers should compare before enrolling

Dr. Jay Zigmont, founder of Childfree Trust, on a new survey showing financial planning is missing the mark for childfree adults

Dr. Jay Zigmont, founder of Childfree Trust and Childfree Wealth, joins Tony to discuss a new national survey finding that 59% of childfree adults say the financial advice they have encountered focuses on building future wealth rather than helping them enjoy life today, and why a growing segment of Americans without children need financial planning that reflects their actual lives, priorities and legacy goals.

Sarah Kennedy, founder and CEO of Calocurb, on natural GLP-1 activation and muscle preservation in weight loss

Sarah Kennedy, founder and CEO of Calocurb, joins Tony to discuss new clinical research showing that GLP-1 weight loss medications may cause significant muscle loss alongside fat loss, and how Calocurb, a natural GLP-1 activator backed by 15 years of New Zealand government-funded science, offers an alternative for those seeking fat loss without the muscle preservation concerns associated with prescription GLP-1 injections.

Dr. James Atkinson and Kenny Pyle of SHRM on new research into AI in the workplace

Dr. James Atkinson, vice president of thought leadership at SHRM, and Kenny Pyle, HR technology lead analyst at SHRM, join Tony to discuss new research finding that only 41% of U.S. workers currently use AI on the job, nearly half of those users say their output includes low-quality AI-generated content, and that organizational trust and a culture that values critical thinking are key to driving engagement when AI is introduced.